https://www.marketscreener.com/quote/stock/TRANSGENE-4789/news/Transgene-Expands-Phase-II-Clinical-Trial-of-Therapeutic-Vaccine-TG4001-in-Combination-With-Avelumab-33485565/?utm_source=telegram&utm_medium=social&utm_campaign=share